Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Elekta

57.85 SEK

-4.62 %

Less than 1K followers

EKTA B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-4.62 %
+4.14 %
+1.94 %
+6.44 %
+17.82 %
-0.43 %
-30.35 %
-49.70 %
+563.15 %

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Read more
Market cap
22.19B SEK
Turnover
69.59M SEK
Revenue
18.02B
EBIT %
4.94 %
P/E
93.31
Dividend yield-%
4.15 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/5
2026

Annual report '26

27/8
2026

Interim report Q1'27

3/9
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release3/5/2026, 6:30 AM

Tredje kvartalet, november–januari 2025/26

Elekta
Regulatory press release3/5/2026, 6:30 AM

Third quarter, November–January 2025/26

Elekta
Regulatory press release3/3/2026, 5:18 PM

Finansinspektionen: Flaggningsmeddelande i Elekta AB (publ)

Elekta

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/25/2026, 6:30 AM

Förändring i Elektas valberedning inför årsstämman 2026

Elekta
Regulatory press release2/25/2026, 6:30 AM

Change in Elekta’s Nomination Committee for the Annual General Meeting 2026

Elekta
Press release2/19/2026, 6:30 AM

Inbjudan till Elektas Q3 2025/26-presentation kl. 9.00 CET den 5 mars

Elekta
Press release2/19/2026, 6:30 AM

Invitation to Elekta’s Q3 2025/26 call at 9:00 a.m. CET, March 5

Elekta
Press release1/30/2026, 11:00 AM

Elekta presenterar strategisk uppdatering: tillväxt, innovation och operativ excellens

Elekta
Press release1/30/2026, 11:00 AM

Elekta presents Strategic Update: growth, innovation, and operations

Elekta
Press release1/23/2026, 10:10 AM

Elekta utser Tomas Eliasson till vice ordförande i styrelsen

Elekta
Press release1/23/2026, 10:10 AM

Elekta appoints Tomas Eliasson as Vice Chair of the Board

Elekta
Regulatory press release1/16/2026, 8:54 AM

Elekta får FDA 510(k)-godkännande för linjäracceleratorn Elekta Evo

Elekta
Regulatory press release1/16/2026, 8:54 AM

Elekta receives FDA 510(k) clearance for Elekta Evo linear accelerator

Elekta
Press release1/12/2026, 9:00 AM

Inbjudan till Elektas Strategiska Uppdatering den 30 januari

Elekta
Press release1/12/2026, 9:00 AM

Invitation to Elekta's Strategic Update event on January 30

Elekta
Regulatory press release12/23/2025, 9:00 AM

Finansinspektionen: Flaggningsmeddelande i Elekta AB (publ)

Elekta
Regulatory press release12/22/2025, 11:48 AM

Finansinspektionen: Flaggningsmeddelande i Elekta AB (publ)

Elekta
Regulatory press release11/26/2025, 6:30 AM

Andra kvartalet, augusti–oktober 2025/26

Elekta
Regulatory press release11/26/2025, 6:30 AM

Second quarter, August–October 2025/26

Elekta
Press release11/12/2025, 6:30 AM

Inbjudan till presentation av Elektas andra kvartal 2025/26

Elekta
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.